,"Author: Winston, Alan",,,,,,,,,,,,
,,,,,,,,,,,,,
,"h index = 10 (Of the 41 documents considered for the h-Index, 10 have been cited at least 10 times.)",,,,,,,,,,,,
,Note: The h Index considers Scopus documents published after 1995.  ,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,<2007,2007,2008,2009,subtotal,>2009,total
Publication Year,Document Title,Authors,ISSN,Journal Title,Volume,Issue,115,60,89,46,195,0,310
2009,"Raltegravir: a new choice in HIV and new chances for research","Emery S., Winston A.",01406736,"The Lancet",374, 9692,0,0,0,0,0,0,0
2009,"Fosamprenavir/ritonavir in advanced HIV disease (TRIAD): A randomized study of high-dose, dual-boosted or standard dose fosamprenavir/ritonavir in HIV-1-infected patients with antiretroviral resistance","Molina J.-M., Lou Y., Givens N., Craig C., Nichols G.W., Barbosa I., Yeo J., Cooper D., Clumeck N., Trottier S., Smith G., Ait-Khaled M., Logue K., Conway B., Tsoukas C., Partisiani M.-L., Sereni D., Lafeuillade A., Bergmann J.-F., Khuong-Josses M.-A., Bouchaud O., Plettenberg A., Rinaldi R., Gargalianos-Kakolyris P., Chrysos G., Sighinolfi L., Mazzotta F., Filice G., Caramello P., Blanco F., Domingo P., Estrada V., Pulido F., Penco G., Terron J.A., Gorgolas M., Coll B., Portilla J., Johnson M., Huengsberg M., Easterbrook P., Winston A., Baril J.-G., Cauda R., Soriano V., Pialoux G., Wire M.B.",03057453,"Journal of Antimicrobial Chemotherapy",64, 2,0,0,0,1,1,0,1
2009,"Detectable cerebrospinal fluid HIV RNA with associated neurological deficits, despite suppression of HIV replication in the plasma compartment","Garvey L.J., Everitt A., Winston A., MacKie N.E., Benzie A.",02699370,"AIDS",23, 11,0,0,0,0,0,0,0
2009,"Rilpivirine: A novel non-nucleoside reverse transcriptase inhibitor","Garvey L., Winston A.",13543784,"Expert Opinion on Investigational Drugs",18, 7,0,0,0,0,0,0,0
2009,"Pgp3 antibody enzyme-linked immunosorbent assay, a sensitive and specific assay for seroepidemiological analysis of Chlamydia trachomatis infection","Wills G.S., McClure M.O., Horner P.J., Reynolds R., Johnson A.M., Muir D.A., Brown D.W., Winston A., Broadbent A.J., Parker D.",15566811,"Clinical and Vaccine Immunology",16, 6,0,0,0,0,0,0,0
2008,"Clinical application of the inhibitory quotient: Is there a role in HIV protease inhibitor therapy?","Winston A., Khoo S.",1746630X,"Current Opinion in HIV and AIDS",3, 6,0,0,0,0,0,0,0
2008,"Factors influencing efavirenz and nevirapine plasma concentration: Effect of ethnicity, weight and co-medication","Stohr W., Pozniak A., Leen C., Bansi L., Fisher M., Orkin C., Anderson J., Johnson M., Easterbrook P., Gibbons S., Khoo S.H., Back D., Dunn D., Sabin C., Winston A., Gilson R., Pillay D., Hill T., Ainsworth J.",13596535,"Antiviral Therapy",13, 5,0,0,0,4,4,0,4
2008,"An unusual abacavir reaction","Fox J., Newton P., Daly R., Blume A., Marett B., Greene L., Winston A.",02699370,"AIDS",22, 12,0,0,1,1,2,0,2
2008,"Concomitant use of nonnucleoside analogue reverse transcriptase inhibitors and rifampicin in TB/HIV type 1-coinfected patients","Sathia L., Obiorah I., Taylor G., Kon O., O'Donoghue M., Gibbins S., Walsh J., Winston A.",08892229,"AIDS Research and Human Retroviruses",24, 7,0,0,0,0,0,0,0
2007,"Response to ""Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment"" [2]","Garvey L., Thomson E.C., Main J., Winston A.",15254135,"Journal of Acquired Immune Deficiency Syndromes",46, 5,0,0,0,0,0,0,0
2007,"Polymorphisms at position 245 of HIV reverse transcriptase do not accurately predict the presence of human leukocyte antigen B*5701 [4]","Waters L.J., Mackie N.E., Pozniak A., Winston A.",10584838,"Clinical Infectious Diseases",45, 9,0,0,0,2,2,0,2
2007,"Pharyngeal gonorrhoea - Is dual therapy the way forward?","Sathia L., Ellis B., Phillip S., Winston A., Smith A.",09564624,"International Journal of STD and AIDS",18, 9,0,0,0,4,4,0,4
2007,"Are disulfiram-like reactions associated with abacavir-containing antiretroviral regimens in clinical practice?","Barber T.J., Marett B., Waldron S., Portsmouth S., MacKie N.E., Weston R., Winston A.",02699370,"AIDS",21, 13,0,0,3,0,3,0,3
2007,"Pharmacokinetics and antiretroviral response to darunavir/ritonavir and etravirine combination in patients with high-level viral resistance","Boffito M., Miralles D., Gazzard B., Winston A., Jackson A., Fletcher C., Pozniak A., Nelson M., Moyle G., Tolowinska I., Hoetelmans R.",02699370,"AIDS",21, 11,0,4,18,12,34,0,34
2007,"The safety, efficacy and pharmacokinetic profile of a switch in antiretroviral therapy to saquinavir, ritonavir, and atazanavir alone for 48 weeks and a switch in the saquinavir formulation","Winston A., Mallon P.W.G., Satchell C., MacRae K., Williams K.M., Schutz M., Law M., Cooper D.A., Emery S.",10584838,"Clinical Infectious Diseases",44, 11,0,1,6,1,8,0,8
2007,"Combining resistance and pharmacology for optimum patient care","Khoo S.H., Winston A., Back D.J.",1746630X,"Current Opinion in HIV and AIDS",2, 3,0,1,1,1,3,0,3
2007,"Pharmacokinetics of experimental antiretroviral agents","Barber T.J., Winston A.",17460794,"Future Virology",2, 1,0,0,0,0,0,0,0
2006,"The clinical pharmacology of antiretrovirals in development","Winston A., Mallon P.W.G., Boffito M.",17425255,"Expert Opinion on Drug Metabolism and Toxicology",2, 3,0,1,2,1,4,0,4
2006,"Erratum: Is screening for sexually transmitted infections in men who have sex with men who receive non-occupational HIV post-exposure prophylaxis worthwhile? (Sexually Transmitted Infections (2006) 82 (21-23))","Hamlyn E., McAllister J., Winston A., Manavi K.",13684973,"Sexually Transmitted Infections",82, 5,0,0,0,0,0,0,0
2006,"Effect of omeprazole on the pharmacokinetics of saquinavir-500 mg formulation with ritonavir in healthy male and female volunteers","Winston A., Boffito M., Back D., Fletcher C., Robinson L., Unsworth J., Tolowinska I., Schutz M., Pozniak A.L., Gazzard B.",02699370,"AIDS",20, 10,1,7,5,2,14,0,15
2006,"The clinical implications of antiretroviral pharmacogenomics","Fox J., Boffito M., Winston A.",14622416,"Pharmacogenomics",7, 4,0,2,3,1,6,0,6
2006,"Different methods to calculate the inhibitory quotient of boosted single protease inhibitors and their association with virological response [1]","Winston A., Gazzard B., Boffito M., Patel N., Back D., Khoo S., Bulbeck S., Mandalia S., Pozniak A.L., Nelson M., Moyle G.",15254135,"Journal of Acquired Immune Deficiency Syndromes",41, 5,0,2,1,0,3,0,3
2006,"Nonnucleoside reverse transcriptase inhibitor fold change or plasma concentration as a predictor of virological response over 48 weeks in highly treatment experienced hiv-positive individuals","Winston A., Amin J., Hales G., Cooper D.A., Emery S.",08892229,"AIDS Research and Human Retroviruses",22, 4,0,0,0,0,0,0,0
2006,"Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy","Winston A., Amin J., Mallon P.W.G., Marriott D., Carr A., Cooper D.A., Emery S.",14642662,"HIV Medicine",7, 2,5,7,14,6,27,0,32
2006,"Is screening for sexually transmitted infections in men who have sex with men who receive non-occupational HIV post-exposure prophylaxis worthwhile?","Hamlyn E., McAllister J., Winston A., Sinclair B., Amin J., Carr A., Cooper D.A.",13684973,"Sexually Transmitted Infections",82, 1,0,1,2,0,3,0,3
2005,"Host determinants of antiretroviral drug activity","Boffito M., Winston A., Owen A.",09517375,"Current Opinion in Infectious Diseases",18, 6,1,4,0,0,4,0,5
2005,"The rationale and development of new drugs to treat HIV infection.","Stebbing J., Hatzimichael E., Bower M., Winston A.",15734064,"Medicinal chemistry",1, 6,1,0,1,0,1,0,2
2005,"The normalized inhibitory quotient of boosted protease inhibitors is predictive of viral load response in treatment-experienced HIV-1-infected individuals","Winston A., Hales G., Amin J., Van Schaick E., Cooper D.A., Emery S.",02699370,"AIDS",19, 13,3,4,5,1,10,0,13
2005,"Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy","Winston A., Bloch M., Carr A., Amin J., Mallon P.W.G., Ray J., Marriott D., Cooper D.A., Emery S.",03057453,"Journal of Antimicrobial Chemotherapy",56, 2,12,4,2,2,8,0,20
2005,"The management of HIV-1 protease inhibitor pharmacokinetic interactions","Winston A., Boffito M.",03057453,"Journal of Antimicrobial Chemotherapy",56, 1,9,9,6,1,16,0,25
2005,"The use of a triple nucleoside-nucleotide regimen for nonoccupational HIV post-exposure prophylaxis","Winston A., McAllister J., Amin J., Cooper D.A., Carr A.",14642662,"HIV Medicine",6, 3,6,4,3,1,8,0,14
2005,"Early syphilis presenting as a painful polyradiculopathy in an HIV positive individual","Winston A., Marriott D., Brew B.",13684973,"Sexually Transmitted Infections",81, 2,1,0,0,1,1,0,2
2005,"New drugs for old.","Winston A., Stebbing J.",14620308,"Journal of HIV therapy",10, 1,1,0,0,0,0,0,1
2004,"The K65R mutation in HIV-1 reverse transcriptase.","Winston A., Stebbing J.",14620308,"Journal of HIV therapy",9, 2,1,0,0,0,0,0,1
2004,"Which nucleoside and nucleotide backbone combinations select for the K65R mutation in HIV-1 reverse transcriptase","Winston A., Pozniak A., Mandalia S., Gazzard B., Pillay D., Nelson M.",02699370,"AIDS",18, 6,33,3,5,2,10,0,43
2004,"Dose escalation or immediate full dose when switching from efavirenz to nevirapine-based highly active antiretroviral therapy in HIV-1-infected individuals?","Winston A., Nelson M., Pozniak A., Smith N., Fletcher C., Mandalia S., Parmar D., Gibbons S., Back D., Gazzard B.",02699370,"AIDS",18, 3,2,2,3,0,5,0,7
2003,"Is increased surveillance for asymptomatic syphilis in an HIV outpatient department worthwhile?","Winston A., Hawkins D., Mandalia S., Boag F., Azadian B., Asboe D.",13684973,"Sexually Transmitted Infections",79, 3,9,0,0,1,1,0,10
2003,"Lack of response of anal intra-epithelial neoplasia to highly active antiretroviral therapy [8]","Fox P., Stebbing J., Portsmouth S., Winston A., Frances N., Nelson M., Gazzard B., Bower M.",02699370,"AIDS",17, 2,10,0,4,1,5,0,15
2002,"The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients","Winston A., Mandalia S., Pillay D., Gazzard B., Pozniak A.",02699370,"AIDS",16, 15,20,4,4,0,8,0,28
2002,"Recurrent hypersensitivity to Combivir","Winston A., McLean K.",09564624,"International Journal of STD and AIDS",13, 3,0,0,0,0,0,0,0
2000,"The use of D-dimers in the diagnosis of occult pulmonary emboli in HIV pulmonary disease - Two case reports","Winston A., Baker R.W., Nelson M., Gazzard B.",09564624,"International Journal of STD and AIDS",11, 10,0,0,0,0,0,0,0
